William F Doyle Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 9 months, 2 weeks ago

William F Doyle has an estimated net worth of at least $10.8 million*, as of May 28, 2025. They own shares of NVCR stock. They have sold 4,217 shares of NVCR stock since 2021, for an estimated $374,124.

William F Doyle $NVCR SEC Form 4 Insider Trading

William F Doyle has filed a total of 3 insider trades in $NVCR since 2021. Their most recent trade was a sale of 837 shares, made on Aug 02, 2022. Their largest trade was a sale of 2,385 shares, made on Mar 08, 2022. We estimate that they now own shares of $NVCR, worth an estimated $10.5 million.

Insider Trading at $NVCR

There have been a total of 192 insider trades reported at $NVCR since 2021, with 106,524 shares purchased and 700,898 shares sold. The most active insider traders in $NVCR stock have been Frank X Leonard, Frank X Leonard, and Ashley Cordova. The most recent trade was a sale of 1,100 shares reported by Nicolas Leupin (Former Chief Medical Officer), made on Mar 04, 2026.

History of Insider Stock Trades by William F Doyle

Company Ticker	Purchase / Sale	Shares	Date	Disclosed (EST)
ELAN	Purchase	15,000	May 21, 2024	May 23, 2024, 4:33 p.m.
ELAN	Purchase	15,000	Mar 08, 2024	March 12, 2024, 4:32 p.m.
NVCR	Sale	837	Aug 02, 2022	Aug. 3, 2022, 4:44 p.m.
NVCR	Sale	2,385	Mar 08, 2022	March 9, 2022, 5:48 p.m.
NVCR	Sale	995	Aug 02, 2021	Aug. 3, 2021, 8 p.m.

$NVCR Executives and Stock Owners with Insider Trades

Frank X Leonard, Chief Development Officer
Frank X Leonard, President, CNS Cancers US
Ashley Cordova, Chief Financial Officer
Asaf Danziger, Chief Executive Officer
Wilhelmus Cm Groenhuysen, Chief Operating Officer
Pritesh Shah, Chief Commercial Officer
Frank X Leonard, EVP, Pres., Novocure Oncology
William Patrick Burke, Chief Human Resources Officer
Ely Benaim, Chief Medical Officer
Mukund Paravasthu, Chief Operating Officer
Pritesh Shah, Chief Growth Officer
Michal Nath Puri, Chief Human Resources Officer
Ashley Cordova, Chief Executive Officer
Uri Weinberg, Chief Science Officer
Christoph Brackmann, Chief Financial Officer
Todd Christopher Longsworth, General Counsel
Uri Weinberg, Chf Medical and Innovation Ofr
William F Doyle, Executive Chairman
Uri Weinberg, Chief Innovation Officer
Nicolas Leupin, Chief Medical Officer
Frank X Leonard, Chief Executive Officer
Nicolas Leupin, Former Chief Medical Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.